Back to Search
GABRIEL LOPEZ-BERESTEIN, M.D.
M.D.
Medical Oncology Physician
NPI: 1497848162Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
F8767(TX)
Research & Publications (20)
Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
PMID 19408305·Int J Cancer·2009
8-other
Signaling mechanisms mediating muscarinic enhancement of GABAergic synaptic transmission in the spinal cord.
PMID 19110040·Neuroscience·2009
7-preclinical
Relaxin/RXFP1 signaling in prostate cancer progression.
PMID 19416223·Ann N Y Acad Sci·2009
7-preclinical
Dual targeting of EphA2 and FAK in ovarian carcinoma.
PMID 19395869·Cancer Biol Ther·2009
7-preclinical
Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells.
PMID 18424910·Autophagy·2008
8-other
Death-associated protein 5 (DAP5/p97/NAT1) contributes to retinoic acid-induced granulocytic differentiation and arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
PMID 18491231·Apoptosis·2008
8-other
The previously undescribed ZKSCAN3 (ZNF306) is a novel "driver" of colorectal cancer progression.
PMID 18519692·Cancer Res·2008
7-preclinical
Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.
PMID 18632639·Cancer Res·2008
7-preclinical
Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.
PMID 18806828·Oncogene·2008
7-preclinical
Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells.
PMID 19088029·Clin Cancer Res·2008
7-preclinical
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes.
PMID 18188003·Autophagy·2008
6-review
Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer.
PMID 18413840·Clin Cancer Res·2008
7-preclinical
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.
PMID 18314475·J Natl Cancer Inst·2008
7-preclinical
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.
PMID 18974154·Cancer Res·2008
7-preclinical
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
PMID 18182619·J Natl Cancer Inst·2008
7-preclinical
Dicer, Drosha, and outcomes in patients with ovarian cancer.
PMID 19092150·N Engl J Med·2008
4-observational
An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic.
PMID 18060038·J Clin Invest·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1497848162
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile